English

AGOURON PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 1999-05-14

21 filing records in this dataset, filed from 1995-04-21 to 1999-05-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

157 million USD

1999-03-31 · USD

Exact inputs and evidence

Revenue: 157483000 USD Source

Operating margin

0.03%

1999-03-31 · %

Exact inputs and evidence

Operating Income: 52000 USD Source
Revenue: 157483000 USD Source

Operating cash flow

16.6 million USD

1999-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 7373000 USD Source
Operating Cash Flow: -9177000 USD Source

Free cash flow

11.2 million USD

1999-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 7373000 USD Source
Operating Cash Flow: -9177000 USD Source
Capital Expenditure: 11362000 USD Source
Capital Expenditure: 6053000 USD Source

Cash and cash equivalents: 42.8 million USD 1999-03-31 Source
Exact value

42775000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

6.5 million USD

1998-04-01 – 1999-03-31

Exact inputs and evidence

Net income: 13154000 USD · 1997-07-01 – 1998-06-30 Source
Net income: 22077000 USD · 1997-07-01 – 1998-03-31 Source
Net income: 6890000 USD · 1998-07-01 – 1998-09-30 Source
Net income: 7620000 USD · 1998-10-01 – 1998-12-31 Source
Net income: 910000 USD · 1999-01-01 – 1999-03-31 Source

Operating cash flow

-29.8 million USD

1998-04-01 – 1999-03-31

Exact inputs and evidence

Operating cash flow: 827000 USD · 1997-07-01 – 1998-06-30 Source
Operating cash flow: 37965000 USD · 1997-07-01 – 1998-03-31 Source
Operating cash flow: -10138000 USD · 1998-07-01 – 1998-09-30 Source
Operating cash flow: -9177000 USD · 1998-07-01 – 1998-12-31 Source
Operating cash flow: -10138000 USD · 1998-07-01 – 1998-09-30 Source
Operating cash flow: 7373000 USD · 1998-07-01 – 1999-03-31 Source
Operating cash flow: -9177000 USD · 1998-07-01 – 1998-12-31 Source

Capital expenditure

19.7 million USD

1998-04-01 – 1999-03-31

Exact inputs and evidence

Capital expenditure: 31507000 USD · 1997-07-01 – 1998-06-30 Source
Capital expenditure: 23200000 USD · 1997-07-01 – 1998-03-31 Source
Capital expenditure: 1636000 USD · 1998-07-01 – 1998-09-30 Source
Capital expenditure: 6053000 USD · 1998-07-01 – 1998-12-31 Source
Capital expenditure: 1636000 USD · 1998-07-01 – 1998-09-30 Source
Capital expenditure: 11362000 USD · 1998-07-01 – 1999-03-31 Source
Capital expenditure: 6053000 USD · 1998-07-01 – 1998-12-31 Source

Free cash flow

-49.4 million USD

1998-04-01 – 1999-03-31

Exact inputs and evidence

Operating cash flow: 827000 USD · 1997-07-01 – 1998-06-30 Source
Operating cash flow: 37965000 USD · 1997-07-01 – 1998-03-31 Source
Operating cash flow: -10138000 USD · 1998-07-01 – 1998-09-30 Source
Operating cash flow: -9177000 USD · 1998-07-01 – 1998-12-31 Source
Operating cash flow: -10138000 USD · 1998-07-01 – 1998-09-30 Source
Operating cash flow: 7373000 USD · 1998-07-01 – 1999-03-31 Source
Operating cash flow: -9177000 USD · 1998-07-01 – 1998-12-31 Source
Capital expenditure: 31507000 USD · 1997-07-01 – 1998-06-30 Source
Capital expenditure: 23200000 USD · 1997-07-01 – 1998-03-31 Source
Capital expenditure: 1636000 USD · 1998-07-01 – 1998-09-30 Source
Capital expenditure: 6053000 USD · 1998-07-01 – 1998-12-31 Source
Capital expenditure: 1636000 USD · 1998-07-01 – 1998-09-30 Source
Capital expenditure: 11362000 USD · 1998-07-01 – 1999-03-31 Source
Capital expenditure: 6053000 USD · 1998-07-01 – 1998-12-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1999-05-14.

Financial data available through: 1998-06-30.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1998-06-30
Operating income: 4 of 11 periods available· newest 1998-06-30
Net income: 6 of 11 periods available· newest 1998-06-30
Operating cash flow: 6 of 11 periods available· newest 1998-06-30
Capital expenditure: 6 of 11 periods available· newest 1998-06-30
Total assets: 6 of 11 periods available· newest 1998-06-30
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 1998-06-30
Current liabilities: 5 of 11 periods available· newest 1998-06-30
Cash and cash equivalents: 6 of 11 periods available· newest 1998-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+253.2%

Prior period

USD 132.06 million

1996-07-01 – 1997-06-30
Current period

USD 466.51 million

1997-07-01 – 1998-06-30

Exact inputs and evidence

466505000 − 132063000 = 334442000 USD

132063000 USD · 1996-07-01 – 1997-06-30
Inspect prior input Prior source
466505000 USD · 1997-07-01 – 1998-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Year-over-year change in Revenue: 334442000 USD Concept: fundies:Revenue Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 466505000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1584 Input fundies:Revenue: 132063000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1584
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 55.96 million

Prior period

−USD 42.81 million

1996-07-01 – 1997-06-30
Current period

USD 13.15 million

1997-07-01 – 1998-06-30

Exact inputs and evidence

13154000 − -42806000 = 55960000 USD

-42806000 USD · 1996-07-01 – 1997-06-30
Inspect prior input Prior source
13154000 USD · 1997-07-01 – 1998-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Year-over-year change in Net income: 55960000 USD Concept: fundies:NetIncome Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 13154000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1755 Input fundies:NetIncome: -42806000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1755
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 74.29 million

Prior period

−USD 73.47 million

1996-07-01 – 1997-06-30
Current period

USD 827,000

1997-07-01 – 1998-06-30

Exact inputs and evidence

827000 − -73467000 = 74294000 USD

-73467000 USD · 1996-07-01 – 1997-06-30
Inspect prior input Prior source
827000 USD · 1997-07-01 – 1998-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Year-over-year change in Operating cash flow: 74294000 USD Concept: fundies:OperatingCashFlow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 827000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767 Input fundies:OperatingCashFlow: -73467000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+154.7%

Prior period

USD 12.37 million

1996-07-01 – 1997-06-30
Current period

USD 31.51 million

1997-07-01 – 1998-06-30

Exact inputs and evidence

31507000 − 12372000 = 19135000 USD

12372000 USD · 1996-07-01 – 1997-06-30
Inspect prior input Prior source
31507000 USD · 1997-07-01 – 1998-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Year-over-year change in Capital expenditure: 19135000 USD Concept: fundies:CapitalExpenditure Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 31507000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729 Input fundies:CapitalExpenditure: 12372000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1997-07-01 – 1998-06-30

Revenue USD 466.51 million 100% of revenue
Operating costs Derived USD 449.74 million 96% of revenue
Operating income USD 16.77 million 3.6% of revenue
Tax, interest and other Derived USD 3.62 million 0.8% of revenue
Net income USD 13.15 million 2.8% of revenue

Cash

Operating cash flow USD 827,000 0.2% of revenue
Capital expenditure USD 31.51 million 6.8% of revenue
Free cash flow Derived −USD 30.68 million −6.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 Not shown: operating income or net income is not reported.
1994 Not shown: operating income or net income is not reported.
1995 Operating loss: operating costs were 149% of revenue.
1996 Operating loss: operating costs were 141% of revenue.
1997 Operating loss: operating costs were 169% of revenue.
1998 96%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1992-07-01 – 1993-06-30	9970000	Unavailable	Unavailable	Unavailable	-9829000	-10208000 Derived	Source 1992-07-01 – 1993-06-30: 9970000 USD Inspect Revenue Open source 1992-07-01 – 1993-06-30: -9829000 USD Inspect Net Income Open source 1992-07-01 – 1993-06-30: -7553000 USD Inspect Operating Cash Flow Open source 1992-07-01 – 1993-06-30: 2655000 USD Inspect Capital Expenditure Open source
1994 1993-07-01 – 1994-06-30	17651000	Unavailable	Unavailable	Unavailable	-9462000	-5276000 Derived	Source 1993-07-01 – 1994-06-30: 17651000 USD Inspect Revenue Open source 1993-07-01 – 1994-06-30: -9462000 USD Inspect Net Income Open source 1993-07-01 – 1994-06-30: -3493000 USD Inspect Operating Cash Flow Open source 1993-07-01 – 1994-06-30: 1783000 USD Inspect Capital Expenditure Open source
1995 1994-07-01 – 1995-06-30	26722000	39811000 Derived	-13089000	-150000 Derived	-12939000	-9444000 Derived	Source 1994-07-01 – 1995-06-30: 26722000 USD Inspect Revenue Open source 1994-07-01 – 1995-06-30: -13089000 USD Inspect Operating Income Open source 1994-07-01 – 1995-06-30: -12939000 USD Inspect Net Income Open source 1994-07-01 – 1995-06-30: -7466000 USD Inspect Operating Cash Flow Open source 1994-07-01 – 1995-06-30: 1978000 USD Inspect Capital Expenditure Open source
1996 1995-07-01 – 1996-06-30	55955000	79092000 Derived	-23137000	-3614000 Derived	-19523000	-11066000 Derived	Source 1995-07-01 – 1996-06-30: 55955000 USD Inspect Revenue Open source 1995-07-01 – 1996-06-30: -23137000 USD Inspect Operating Income Open source 1995-07-01 – 1996-06-30: -19523000 USD Inspect Net Income Open source 1995-07-01 – 1996-06-30: -7814000 USD Inspect Operating Cash Flow Open source 1995-07-01 – 1996-06-30: 3252000 USD Inspect Capital Expenditure Open source
1997 1996-07-01 – 1997-06-30	132063000	223177000 Derived	-91114000	-48308000 Derived	-42806000	-85839000 Derived	Source 1996-07-01 – 1997-06-30: 132063000 USD Inspect Revenue Open source 1996-07-01 – 1997-06-30: -91114000 USD Inspect Operating Income Open source 1996-07-01 – 1997-06-30: -42806000 USD Inspect Net Income Open source 1996-07-01 – 1997-06-30: -73467000 USD Inspect Operating Cash Flow Open source 1996-07-01 – 1997-06-30: 12372000 USD Inspect Capital Expenditure Open source
1998 1997-07-01 – 1998-06-30	466505000	449736000 Derived	16769000	3615000 Derived	13154000	-30680000 Derived	Source 1997-07-01 – 1998-06-30: 466505000 USD Inspect Revenue Open source 1997-07-01 – 1998-06-30: 16769000 USD Inspect Operating Income Open source 1997-07-01 – 1998-06-30: 13154000 USD Inspect Net Income Open source 1997-07-01 – 1998-06-30: 827000 USD Inspect Operating Cash Flow Open source 1997-07-01 – 1998-06-30: 31507000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 466.5M 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-06-30	Revenue	9970000	Revenue: 9970000 Open source
19941994-06-30	Revenue	17651000	Revenue: 17651000 Open source
19951995-06-30	Revenue	26722000	Revenue: 26722000 Open source
19961996-06-30	Revenue	55955000	Revenue: 55955000 Open source
19971997-06-30	Revenue	132063000	Revenue: 132063000 Open source
19981998-06-30	Revenue	466505000	Revenue: 466505000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

253.2% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-06-30	Year over year	No prior comparable period	Revenue: 9970000 Open source
19941994-06-30	Year over year	77%	Revenue: 17651000 Open source Revenue: 9970000 Open source
19951995-06-30	Year over year	51.4%	Revenue: 26722000 Open source Revenue: 17651000 Open source
19961996-06-30	Year over year	109.4%	Revenue: 55955000 Open source Revenue: 26722000 Open source
19971997-06-30	Year over year	136%	Revenue: 132063000 Open source Revenue: 55955000 Open source
19981998-06-30	Year over year	253.2%	Revenue: 466505000 Open source Revenue: 132063000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3.6% 1998

Net margin 2.8% 1998

Free cash flow margin -6.6% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1993-06-30	Operating margin	Not reported	Revenue: 9970000 Open source
1994-06-30	Operating margin	Not reported	Revenue: 17651000 Open source
19951995-06-30	Operating margin	-49%	Operating Income: -13089000 Open source Revenue: 26722000 Open source
19961996-06-30	Operating margin	-41.3%	Operating Income: -23137000 Open source Revenue: 55955000 Open source
19971997-06-30	Operating margin	-69%	Operating Income: -91114000 Open source Revenue: 132063000 Open source
19981998-06-30	Operating margin	3.6%	Operating Income: 16769000 Open source Revenue: 466505000 Open source
19931993-06-30	Net margin	-98.6%	Net Income: -9829000 Open source Revenue: 9970000 Open source
19941994-06-30	Net margin	-53.6%	Net Income: -9462000 Open source Revenue: 17651000 Open source
19951995-06-30	Net margin	-48.4%	Net Income: -12939000 Open source Revenue: 26722000 Open source
19961996-06-30	Net margin	-34.9%	Net Income: -19523000 Open source Revenue: 55955000 Open source
19971997-06-30	Net margin	-32.4%	Net Income: -42806000 Open source Revenue: 132063000 Open source
19981998-06-30	Net margin	2.8%	Net Income: 13154000 Open source Revenue: 466505000 Open source
19931993-06-30	Free cash flow margin	-102.4%	Revenue: 9970000 Open source Operating Cash Flow: -7553000 Open source Capital Expenditure: 2655000 Open source
19941994-06-30	Free cash flow margin	-29.9%	Revenue: 17651000 Open source Operating Cash Flow: -3493000 Open source Capital Expenditure: 1783000 Open source
19951995-06-30	Free cash flow margin	-35.3%	Revenue: 26722000 Open source Operating Cash Flow: -7466000 Open source Capital Expenditure: 1978000 Open source
19961996-06-30	Free cash flow margin	-19.8%	Revenue: 55955000 Open source Operating Cash Flow: -7814000 Open source Capital Expenditure: 3252000 Open source
19971997-06-30	Free cash flow margin	-65%	Revenue: 132063000 Open source Operating Cash Flow: -73467000 Open source Capital Expenditure: 12372000 Open source
19981998-06-30	Free cash flow margin	-6.6%	Revenue: 466505000 Open source Operating Cash Flow: 827000 Open source Capital Expenditure: 31507000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 827K 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-06-30	Operating cash flow	-7553000	Operating Cash Flow: -7553000 Open source
19941994-06-30	Operating cash flow	-3493000	Operating Cash Flow: -3493000 Open source
19951995-06-30	Operating cash flow	-7466000	Operating Cash Flow: -7466000 Open source
19961996-06-30	Operating cash flow	-7814000	Operating Cash Flow: -7814000 Open source
19971997-06-30	Operating cash flow	-73467000	Operating Cash Flow: -73467000 Open source
19981998-06-30	Operating cash flow	827000	Operating Cash Flow: 827000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -30.7M 1998

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-06-30	Free cash flow	-10208000	Operating Cash Flow: -7553000 Open source Capital Expenditure: 2655000 Open source
19941994-06-30	Free cash flow	-5276000	Operating Cash Flow: -3493000 Open source Capital Expenditure: 1783000 Open source
19951995-06-30	Free cash flow	-9444000	Operating Cash Flow: -7466000 Open source Capital Expenditure: 1978000 Open source
19961996-06-30	Free cash flow	-11066000	Operating Cash Flow: -7814000 Open source Capital Expenditure: 3252000 Open source
19971997-06-30	Free cash flow	-85839000	Operating Cash Flow: -73467000 Open source Capital Expenditure: 12372000 Open source
19981998-06-30	Free cash flow	-30680000	Operating Cash Flow: 827000 Open source Capital Expenditure: 31507000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-06-30	Liabilities / assets	Not reported	Total Assets: 41721000 Open source
1994-06-30	Liabilities / assets	Not reported	Total Assets: 37178000 Open source
1995-06-30	Liabilities / assets	Not reported	Total Assets: 27097000 Open source
1996-06-30	Liabilities / assets	Not reported	Total Assets: 102577000 Open source
1997-06-30	Liabilities / assets	Not reported	Total Assets: 266914000 Open source
1998-06-30	Liabilities / assets	Not reported	Total Assets: 363337000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.06× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1993-06-30	Current assets / current liabilities	Not reported	No source recorded
19941994-06-30	Current assets / current liabilities	3.1×	Current Assets: 31080000 Open source Current Liabilities: 10041000 Open source
19951995-06-30	Current assets / current liabilities	1.7×	Current Assets: 21459000 Open source Current Liabilities: 12622000 Open source
19961996-06-30	Current assets / current liabilities	3.79×	Current Assets: 95641000 Open source Current Liabilities: 25260000 Open source
19971997-06-30	Current assets / current liabilities	2.69×	Current Assets: 184201000 Open source Current Liabilities: 68415000 Open source
19981998-06-30	Current assets / current liabilities	2.06×	Current Assets: 247981000 Open source Current Liabilities: 120253000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1992-07-01 – 1993-06-30	−USD 9.83 million Exact value Exact value: -9829000 USD 1992-07-01 – 1993-06-30: -9829000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AGOURON PHARMACEUTICALS INC · 1993-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Net Income: -9829000 USD Concept: fundies:NetIncome Period: 1992-07-01 to 1993-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ANetIncome&period=1993-06-30&surface=latest&period_type=duration&start=1992-07-01&unit=USD&dimensions= Input fundies:NetIncome: -9829000 USD (1992-07-01 to 1993-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-95-000008.txt#1328 The citation records this snapshot. The page link may show a newer release later.	−USD 7.55 million Exact value Exact value: -7553000 USD 1992-07-01 – 1993-06-30: -7553000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AGOURON PHARMACEUTICALS INC · 1993-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Operating Cash Flow: -7553000 USD Concept: fundies:OperatingCashFlow Period: 1992-07-01 to 1993-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3AOperatingCashFlow&period=1993-06-30&surface=latest&period_type=duration&start=1992-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7553000 USD (1992-07-01 to 1993-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-95-000008.txt#1336 The citation records this snapshot. The page link may show a newer release later.	USD 2.66 million Exact value Exact value: 2655000 USD 1992-07-01 – 1993-06-30: 2655000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AGOURON PHARMACEUTICALS INC · 1993-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Capital Expenditure: 2655000 USD Concept: fundies:CapitalExpenditure Period: 1992-07-01 to 1993-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ACapitalExpenditure&period=1993-06-30&surface=latest&period_type=duration&start=1992-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2655000 USD (1992-07-01 to 1993-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-95-000008.txt#1310 The citation records this snapshot. The page link may show a newer release later.	−USD 10.21 million Calculation and evidence -7553000 − 2655000 USD Exact free cash flow: -10208000 USD 1992-07-01 – 1993-06-30: -7553000 USD · Inspect Operating Cash Flow · Source 1992-07-01 – 1993-06-30: 2655000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AGOURON PHARMACEUTICALS INC · 1993-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Free cash flow: -10208000 USD Concept: free-cash-flow Period: 1992-07-01 to 1993-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7553000 USD (1992-07-01 to 1993-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-95-000008.txt#1336 Input fundies:CapitalExpenditure: 2655000 USD (1992-07-01 to 1993-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-95-000008.txt#1310 The citation records this snapshot. The page link may show a newer release later.
1994 1993-07-01 – 1994-06-30	−USD 9.46 million Exact value Exact value: -9462000 USD 1993-07-01 – 1994-06-30: -9462000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AGOURON PHARMACEUTICALS INC · 1994-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Net Income: -9462000 USD Concept: fundies:NetIncome Period: 1993-07-01 to 1994-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ANetIncome&period=1994-06-30&surface=latest&period_type=duration&start=1993-07-01&unit=USD&dimensions= Input fundies:NetIncome: -9462000 USD (1993-07-01 to 1994-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-96-000007.txt#1531 The citation records this snapshot. The page link may show a newer release later.	−USD 3.49 million Exact value Exact value: -3493000 USD 1993-07-01 – 1994-06-30: -3493000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AGOURON PHARMACEUTICALS INC · 1994-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Operating Cash Flow: -3493000 USD Concept: fundies:OperatingCashFlow Period: 1993-07-01 to 1994-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3AOperatingCashFlow&period=1994-06-30&surface=latest&period_type=duration&start=1993-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3493000 USD (1993-07-01 to 1994-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-96-000007.txt#1541 The citation records this snapshot. The page link may show a newer release later.	USD 1.78 million Exact value Exact value: 1783000 USD 1993-07-01 – 1994-06-30: 1783000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AGOURON PHARMACEUTICALS INC · 1994-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Capital Expenditure: 1783000 USD Concept: fundies:CapitalExpenditure Period: 1993-07-01 to 1994-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ACapitalExpenditure&period=1994-06-30&surface=latest&period_type=duration&start=1993-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1783000 USD (1993-07-01 to 1994-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-96-000007.txt#1509 The citation records this snapshot. The page link may show a newer release later.	−USD 5.28 million Calculation and evidence -3493000 − 1783000 USD Exact free cash flow: -5276000 USD 1993-07-01 – 1994-06-30: -3493000 USD · Inspect Operating Cash Flow · Source 1993-07-01 – 1994-06-30: 1783000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AGOURON PHARMACEUTICALS INC · 1994-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Free cash flow: -5276000 USD Concept: free-cash-flow Period: 1993-07-01 to 1994-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3493000 USD (1993-07-01 to 1994-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-96-000007.txt#1541 Input fundies:CapitalExpenditure: 1783000 USD (1993-07-01 to 1994-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-96-000007.txt#1509 The citation records this snapshot. The page link may show a newer release later.
1995 1994-07-01 – 1995-06-30	−USD 12.94 million Exact value Exact value: -12939000 USD 1994-07-01 – 1995-06-30: -12939000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AGOURON PHARMACEUTICALS INC · 1995-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Net Income: -12939000 USD Concept: fundies:NetIncome Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ANetIncome&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:NetIncome: -12939000 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-97-000086.txt#1800 The citation records this snapshot. The page link may show a newer release later.	−USD 7.47 million Exact value Exact value: -7466000 USD 1994-07-01 – 1995-06-30: -7466000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AGOURON PHARMACEUTICALS INC · 1995-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Operating Cash Flow: -7466000 USD Concept: fundies:OperatingCashFlow Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3AOperatingCashFlow&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7466000 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-97-000086.txt#1811 The citation records this snapshot. The page link may show a newer release later.	USD 1.98 million Exact value Exact value: 1978000 USD 1994-07-01 – 1995-06-30: 1978000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AGOURON PHARMACEUTICALS INC · 1995-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Capital Expenditure: 1978000 USD Concept: fundies:CapitalExpenditure Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ACapitalExpenditure&period=1995-06-30&surface=latest&period_type=duration&start=1994-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1978000 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-97-000086.txt#1775 The citation records this snapshot. The page link may show a newer release later.	−USD 9.44 million Calculation and evidence -7466000 − 1978000 USD Exact free cash flow: -9444000 USD 1994-07-01 – 1995-06-30: -7466000 USD · Inspect Operating Cash Flow · Source 1994-07-01 – 1995-06-30: 1978000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AGOURON PHARMACEUTICALS INC · 1995-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Free cash flow: -9444000 USD Concept: free-cash-flow Period: 1994-07-01 to 1995-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7466000 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-97-000086.txt#1811 Input fundies:CapitalExpenditure: 1978000 USD (1994-07-01 to 1995-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-97-000086.txt#1775 The citation records this snapshot. The page link may show a newer release later.
1996 1995-07-01 – 1996-06-30	−USD 19.52 million Exact value Exact value: -19523000 USD 1995-07-01 – 1996-06-30: -19523000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AGOURON PHARMACEUTICALS INC · 1996-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Net Income: -19523000 USD Concept: fundies:NetIncome Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ANetIncome&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:NetIncome: -19523000 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1755 The citation records this snapshot. The page link may show a newer release later.	−USD 7.81 million Exact value Exact value: -7814000 USD 1995-07-01 – 1996-06-30: -7814000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AGOURON PHARMACEUTICALS INC · 1996-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Operating Cash Flow: -7814000 USD Concept: fundies:OperatingCashFlow Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3AOperatingCashFlow&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7814000 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767 The citation records this snapshot. The page link may show a newer release later.	USD 3.25 million Exact value Exact value: 3252000 USD 1995-07-01 – 1996-06-30: 3252000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AGOURON PHARMACEUTICALS INC · 1996-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Capital Expenditure: 3252000 USD Concept: fundies:CapitalExpenditure Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ACapitalExpenditure&period=1996-06-30&surface=latest&period_type=duration&start=1995-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3252000 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729 The citation records this snapshot. The page link may show a newer release later.	−USD 11.07 million Calculation and evidence -7814000 − 3252000 USD Exact free cash flow: -11066000 USD 1995-07-01 – 1996-06-30: -7814000 USD · Inspect Operating Cash Flow · Source 1995-07-01 – 1996-06-30: 3252000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AGOURON PHARMACEUTICALS INC · 1996-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Free cash flow: -11066000 USD Concept: free-cash-flow Period: 1995-07-01 to 1996-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7814000 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767 Input fundies:CapitalExpenditure: 3252000 USD (1995-07-01 to 1996-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729 The citation records this snapshot. The page link may show a newer release later.
1997 1996-07-01 – 1997-06-30	−USD 42.81 million Exact value Exact value: -42806000 USD 1996-07-01 – 1997-06-30: -42806000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AGOURON PHARMACEUTICALS INC · 1997-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Net Income: -42806000 USD Concept: fundies:NetIncome Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ANetIncome&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:NetIncome: -42806000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1755 The citation records this snapshot. The page link may show a newer release later.	−USD 73.47 million Exact value Exact value: -73467000 USD 1996-07-01 – 1997-06-30: -73467000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AGOURON PHARMACEUTICALS INC · 1997-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Operating Cash Flow: -73467000 USD Concept: fundies:OperatingCashFlow Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3AOperatingCashFlow&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -73467000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767 The citation records this snapshot. The page link may show a newer release later.	USD 12.37 million Exact value Exact value: 12372000 USD 1996-07-01 – 1997-06-30: 12372000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AGOURON PHARMACEUTICALS INC · 1997-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Capital Expenditure: 12372000 USD Concept: fundies:CapitalExpenditure Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ACapitalExpenditure&period=1997-06-30&surface=latest&period_type=duration&start=1996-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12372000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729 The citation records this snapshot. The page link may show a newer release later.	−USD 85.84 million Calculation and evidence -73467000 − 12372000 USD Exact free cash flow: -85839000 USD 1996-07-01 – 1997-06-30: -73467000 USD · Inspect Operating Cash Flow · Source 1996-07-01 – 1997-06-30: 12372000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AGOURON PHARMACEUTICALS INC · 1997-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Free cash flow: -85839000 USD Concept: free-cash-flow Period: 1996-07-01 to 1997-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -73467000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767 Input fundies:CapitalExpenditure: 12372000 USD (1996-07-01 to 1997-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729 The citation records this snapshot. The page link may show a newer release later.
1998 1997-07-01 – 1998-06-30	USD 13.15 million Exact value Exact value: 13154000 USD 1997-07-01 – 1998-06-30: 13154000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Net Income: 13154000 USD Concept: fundies:NetIncome Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ANetIncome&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:NetIncome: 13154000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1755 The citation records this snapshot. The page link may show a newer release later.	USD 827,000 Exact value Exact value: 827000 USD 1997-07-01 – 1998-06-30: 827000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Operating Cash Flow: 827000 USD Concept: fundies:OperatingCashFlow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3AOperatingCashFlow&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 827000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767 The citation records this snapshot. The page link may show a newer release later.	USD 31.51 million Exact value Exact value: 31507000 USD 1997-07-01 – 1998-06-30: 31507000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Capital Expenditure: 31507000 USD Concept: fundies:CapitalExpenditure Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210/explain?concept=fundies%3ACapitalExpenditure&period=1998-06-30&surface=latest&period_type=duration&start=1997-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31507000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729 The citation records this snapshot. The page link may show a newer release later.	−USD 30.68 million Calculation and evidence 827000 − 31507000 USD Exact free cash flow: -30680000 USD 1997-07-01 – 1998-06-30: 827000 USD · Inspect Operating Cash Flow · Source 1997-07-01 – 1998-06-30: 31507000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AGOURON PHARMACEUTICALS INC · 1998-06-30 AGOURON PHARMACEUTICALS INC (edgar:811210) Free cash flow: -30680000 USD Concept: free-cash-flow Period: 1997-07-01 to 1998-06-30 Values: Latest reported Published: 2026-11-02T23:03:31Z Snapshot: 3c9c426391d86748400509d5b1fec1f1a9a118d77665c66329ac4a3f2e1bfa01 Dimensions: Consolidated View: https://fundies.io/companies/edgar/811210?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 827000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1767 Input fundies:CapitalExpenditure: 31507000 USD (1997-07-01 to 1998-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/811210/0000811210-98-000015.txt#1729 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

21 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000811210, 811210, edgar:811210

AGOURON PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1998 1997-07-01 – 1998-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation